North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.125

-17.9%

12:57 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Bogdanoff who wrote (309)	2/25/1998 2:12:00 PM
From: David Bogdanoff	Read Replies (1) of 507

To all; There is a very interesting article on bioengineered vaccines on page B1 of today's WSJ. Briefly, the author sees a big growth in vaccines because of new diseases treatable by bioengineered vaccines, such as a vaccine for children's ear infection. Merck, Connaught, SKB, and AHP and some of their vaccine disease targets are mentioned; NVX is not mentioned. I think the article helps put this industry in perspective even though it does not directly address NVX. David PS Anyone feel that this article either helps or hurts NVX?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next